Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Eduardo Lasalvia-Galante"'
Autor:
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Jesús Vázquez, Marta Aghazarian, Eduardo Lasalvia-Galante, et al
Publikováno v:
Biologics: Targets & Therapy, Vol 2008, Iss Issue 3, Pp 555-561 (2008)
Eduardo Lasalvia-Prisco1,4, Emilio Garcia-Giralt2, Jesús Vázquez2,4, Marta Aghazarian4, Eduardo Lasalvia-Galante3,4, Joshemaria Larrañaga3,4, Gonzalo Spera31Interdoctors Medical Procedures, North Miami Beach, FL, USA; 2Centre De Cancérologie Hart
Externí odkaz:
https://doaj.org/article/eca5ef6a247b466e8d53d912c069ba11
Publikováno v:
Multidisciplinary Cancer Investigation. :20-36
Autor:
Alvaro L, Ronco, Edison, Espinosa, Juan M, Calderon, Eduardo, Lasalvia- Galante, Alejandro, De Rosa, Gustavo, Sanchez
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Previous reports on the inverse association between ‘mate’ intake (infusion of Ilex Paraguariensis herb) and breast cancer (BC) risk led us to consider two main roles for the infusion: as a substantial antioxidant contributor and as a hormone reg
Autor:
Pablo Goldschmidt, Wilson Golomar, Eduardo Lasalvia-Galante, William Gordon, Martha Aghazarian, Eduardo Lasalvia-Prisco, Felipe C. Galmarini, Jesús Vázquez, S. Cucchi
Publikováno v:
Medical Oncology (Northwood, London, England)
Studies have shown that cancer requires two conditions for tumor progression: cancer cell proliferation and an environment permissive to and conditioned by malignancy. Chemotherapy aims to control the number and proliferation of cancer cells, but it
Autor:
S. Cucchi, Eduardo Lasalvia-Prisco, Jesús Vázquez, Eduardo Lasalvia-Galante, William Gordon, Wilson Golomar
Publikováno v:
Cancer Chemotherapy and Pharmacology. 53:220-224
It has been reported that insulin increases the cytotoxic effect in vitro of methotrexate by as much as 10,000-fold. The purpose of this study was to explore the clinical value of insulin as a potentiator of methotrexate.Included in this prospective,
Autor:
Eduardo Lasalvia-Prisco, Jesús Vázquez, William Gordon, Wilson Golomar, Eduardo Lasalvia-Galante, S. Cucchi
Publikováno v:
Cancer Biology & Therapy. 2:155-160
Lately, the promising results obtained with autologous cancer vaccines are stimulating new research in the old field of cancer immunotherapy. This paper describes the development of a procedure previously reported by us that is used to obtain an auto
Autor:
Eduardo Lasalvia-Prisco, Eduardo Lasalvia-Galante, Wilson Golomar, Joshemaria Larrañaga, S. Cucchi, Jesús Vázquez, Emilio Garcia-Giralt
Publikováno v:
Breast cancer research and treatment. 100(2)
Introduction Advanced breast cancer patients, acquired-chemotherapy resistant and in progression, are therapeutically terminal. We tested a recently described medical procedure using a thermostable autohemoderivative purported to inhibit tumor growth
Autor:
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Eduardo Lasalvia-Galante, S. Cucchi, Wilson Golomar, Joshemaria Larrañaga, Jesús Vázquez
Publikováno v:
Medical oncology (Northwood, London, England). 23(1)
Advanced colon cancer patients, acquired-chemotherapy resistant and in progression, are therapeutically terminal. We tested a recently described medical procedure using a thermostable autologous hemoderivative purported to inhibit tumor growth possib
Autor:
Eduardo Lasalvia-Prisco, William Gordon, Wilson Golomar, Jesús Vázquez, Eduardo Lasalvia-Galante, S. Cucchi
Publikováno v:
Medical oncology (Northwood, London, England). 20(1)
In vitro exposure of malignant prostate cell lines to ascorbic acid-menadione showed that tumor cells were killed through a mechanism named autoschizis. Experimental animal studies showed that autoschizis is also evident when ascorbic acid-menadione
Autor:
Felipe C. Galmarini, Eduardo Lasalvia-Galante, S. Cucchi, Jesús Vázquez, Eduardo Lasalvia-Prisco, Wilson Golomar, Pablo Goldschmidt
Publikováno v:
Journal of Clinical Oncology. 30:e13105-e13105
e13105 Background: Successive developed configurations of Autologous Heterotopic Transplant of Peripheral Blood (AHTOPB) were reported lately. In advanced stages of different primary tumors, AHTOPB has improved the antitumoral effect of chemotherapy